Skip to main content
Caplight Logo









Epitype GmbH

Epitype GmbH

Private
LeipzigHealthcare & Life Scienceshttps://www.epitype.de/

Last Round

VC Round

Sep 5, 2023

Total Funding Raised

$3.98M

Company Overview

Epitype GmbH is a molecular diagnostics company that has developed a proprietary technology platform for sensitive DNA-methylation-based biomarkers for the early diagnosis of cancer and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

molecular diagnosticsepigenetic diagnosticscervical cancer diagnosticsin-vitro diagnosticsIVDDNA methylationepigenetic biomarkersHPV triagediagnostic test kitscancer diagnosticstriage testbiomarker discoverytechnology licensingliquid biopsymethylation-specific PCRISO 13485

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epitype GmbH Comparables

Compare Epitype GmbH with similar companies based on industry and business-model similarity.

Epitype GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Guzip Biomarkers Corporation
83%
Qiagen
78%
China National Pharmaceutical Group
71%

Epitype GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 5, 2023
CrowdfundingOct 18, 2018
CrowdfundingSep 26, 2016
Series AJan 29, 2015
SeedApr 19, 2012

Epitype GmbH Investors

Notable investors and investment history

Epitype GmbH investors
InvestorRounds
Sparkasse Jena-Saale-HolzlandSeries A
Stiftung für Technologie, Innovation und Forschung ThüringenSeries A, Seed
OneCrowdCrowdfunding
bm|t beteiligungsmanagement thüringenCrowdfunding, VC Round, Series A
High-Tech GründerfondsSeries A, Seed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 5, 2023

    $1.07M round from High-Tech Gründerfonds and bm|t.

  • Oct 18, 2018

    $1.7M raised from OneCrowd and bm|t.

Epitype GmbH Filings

Explore SEC and related filing metadata, where available.

Epitype GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Epitype GmbH's valuation, stock price, and market status.

Is Epitype GmbH a public or private company?

Epitype GmbH is a private company.

What is the current stock price of Epitype GmbH?

Epitype GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is Epitype GmbH worth (valuation)?

Valuation information for Epitype GmbH is not publicly available.

Can I buy Epitype GmbH stock?

Epitype GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Epitype GmbH's last funding round?

Epitype GmbH's most recent funding round was VC Round on September 5, 2023.

Who are the main investors in Epitype GmbH?

Key investors in Epitype GmbH include bm|t beteiligungsmanagement thüringen.

Will Epitype GmbH IPO soon?

No public IPO plans have been announced for Epitype GmbH.

How can I track Epitype GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Epitype GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLeipzig
Employee Range20
Year Founded2020
Last FundingSep 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?